Our study indicates that HLA-DR expression on CD14-CD16+ monocytes and CD14+ CD16+ monocytes has a protective effect against PBC, while HLA-DR+ natural killer cells offer protection against AIH. Here, CD14 is linked to autoimmune hepatitis.